We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug & Device Products
FDAnews Books Library
Events
Form 483s Database
Publications
Webinar Training Pass
eCFR and Guidances
Books
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Russell K. Riley
Russell K. Riley
Products
PRODUCTS
Valeant Pharmaceuticals International, Inc.
Russell K. Riley
Price:
$117.00
View
BMC 1092, Inc. dba Solo Laboratories, Inc.
Russell K. Riley
Price:
$117.00
View
Central Illinois Compounding, Inc. dba Preckshot Professiona
Russell K. Riley
Price:
$117.00
View
National Prescription Services, Inc.
Russell K. Riley
Price:
$117.00
View
Universal Holdings I, LLC
Russell K. Riley
Price:
$117.00
View
Martin Avenue Pharmacy, Inc.
Russell K. Riley
Price:
$117.00
View
Blue island Phenol LLC
Russell K. Riley
Price:
$117.00
View
Mericon Industries, Inc.
Russell K. Riley
Price:
$117.00
View
Akorn, Inc.
Russell K. Riley
and
Rebeca Rodriguez
Price:
$117.00
View
Fresenius Kabi USA LLC
Russell K. Riley
and
John M. Seale
Price:
$117.00
View
View All Products by Russell K. Riley
Upcoming Events
13
Jul
FDA Ad and Promo Enforcement Trends: Past, Present and Future
27
Jul
Applying the Lessons of the Pandemic to Your Upcoming Trial
28
Jul
EU-MDR’s Growing Pains: Are You Current with the Latest Developments?
02
Aug
Medical Device Cybersecurity: Understand the Latest Developments
03
Aug
Pharmaceutical Process Validation: Best Practices for Success
10
Aug
Gene & Cell Therapy Regulation: Comparability and Other New Developments
Featured Products
FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485
Selecting and Implementing Electronic Document Management Systems in the EU
Featured Stories
FDA Approves Foundation Medicine’s Companion Diagnostic for Genentech’s Rozlytrek
Novartis Pays $100 Million for Mallinckrodt’s Priority Review Voucher
FDA Approves Beyond Air’s LungFit PH for Newborn Pulmonary Hypertension
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
